Company record
Alercell produces and supplies rapid diagnostic test kits together with antigen‑analysis instruments for medical use. Its product line includes rapid serology assays, polymerase chain reaction (PCR) platforms, saliva‑based tests and dedicated COVID‑19 solutions. These kits are validated for detecting influenza viruses, syphilis, dengue and hepatitis A, B, and C. Customers span blood banks, clinical laboratories, hospitals, outpatient clinics, physicians’ offices and government health agencies. All offerings are FDA‑approved and carry the CE certification.
This directory record does not yet have a linked material-flow brief.